INTESTINAL FIBROSIS

This adverse event was reported 216 times

These drugs are most commonly taken by patients reporting INTESTINAL FIBROSIS:

# Drug Count
0 ADALIMUMAB 142
1 METHOTREXATE SODIUM 34
2 PREDNISONE 34
3 AZATHIOPRINE 32
4 METHOTREXATE 26
5 INFLIXIMAB 14
6 ERGOCALCIFEROL 12
7 LOPERAMIDE HYDROCHLORIDE 9
8 VEDOLIZUMAB 9
9 CHOLESTYRAMINE 8
See all common drugs associated with INTESTINAL FIBROSIS

INTESTINAL FIBROSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PHENOBARBITAL, HYOSCYAMINE SULFATE, ATROPINE SULFATE, SCOPOLAMINE HYDROBROMIDE 1 0.0011
1 CYSTEAMINE BITARTRATE 1 0.0010
2 PIOGLITAZONE HYDROCHLORIDE 1 0.0008
3 AZATHIOPRINE SODIUM 2 0.0008
4 CHOLESTYRAMINE 8 0.0007
5 NEOMYCIN OINTMENT 1 0.0004
6 LOMUSTINE 1 0.0004
7 AZATHIOPRINE 32 0.0004
8 AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE 1 0.0003
9 ELAGOLIX 1 0.0003
See all drugs enriched for association with INTESTINAL FIBROSIS

INTESTINAL FIBROSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bile Acid Sequestrant [EPC] 8 0.0007
1 Purine Antimetabolite [EPC] 32 0.0003
2 Cephalosporin Antibacterial [EPC] 1 0.0001
3 Interleukin-12 Antagonist [EPC] 8 0.0001
4 Nicotinic Acid [EPC] 4 0.0001
5 Folate Analog [EPC] 3 0.0001
6 Folate Analog Metabolic Inhibitor [EPC] 26 0.0001
7 Vitamin A [EPC] 3 0.0001
8 Interleukin-23 Antagonist [EPC] 13 0.0001
9 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
See all drug classes enriched for association with INTESTINAL FIBROSIS